Vatner S F, Patrick T A, Knight D R, Manders W T, Fallon J T
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Circ Res. 1988 Jan;62(1):105-15. doi: 10.1161/01.res.62.1.105.
Two groups of chronically instrumented, conscious baboons were studied. The effects of coronary artery occlusion for 3 hours and reperfusion for 1 week were examined on measurements of left ventricular function, ischemic-zone wall thickness, regional myocardial blood flow, arrhythmias, and extent of necrosis. The experimental group of animals (n = 7) was treated with the calcium channel blocker nisoldipine (0.1 microgram/kg/min) from 1 hour after coronary occlusion to 3 hours after coronary reperfusion. The control group (n = 6) received the vehicle (n = 4) or saline (n = 2). The effects of coronary artery occlusion and reperfusion on arterial pressure, left ventricular systolic pressure, heart rate, and left ventricular dP/dt were similar in both groups. Systolic wall thickening was reversed to paradoxical wall thinning during occlusion in both groups, and there was no recovery to systolic wall thickening over the 1-week period in either group. There were differences in regional blood flow; during coronary artery occlusion, nisoldipine increased blood flow significantly in the endocardium and epicardium of nonischemic and ischemic zones. There was a major difference in the number of arrhythmic beats per minute on reperfusion; during reperfusion, the number of arrhythmias rose markedly in the vehicle-treated group but actually fell in the nisoldipine-treated group. The size of areas at risk, infarcts, infarcts related to the area at risk, and amount of total creatine kinase (CK) and MB-CK appearing in blood were not significantly different in the two groups. Thus, in the conscious baboon, nisoldipine administered 1 hour after coronary artery occlusion exerted a marked effect in diminishing reperfusion-induced arrhythmias and improved blood flow to the ischemic zone during occlusion but did not salvage ischemic tissue.
对两组长期植入仪器的清醒狒狒进行了研究。研究了冠状动脉闭塞3小时及再灌注1周对左心室功能、缺血区壁厚度、局部心肌血流量、心律失常及坏死范围测量的影响。实验组动物(n = 7)在冠状动脉闭塞后1小时至冠状动脉再灌注后3小时接受钙通道阻滞剂尼索地平(0.1微克/千克/分钟)治疗。对照组(n = 6)接受溶媒(n = 4)或生理盐水(n = 2)。两组中冠状动脉闭塞和再灌注对动脉压、左心室收缩压、心率及左心室dP/dt的影响相似。两组在闭塞期间收缩期壁增厚均逆转为矛盾性壁变薄,且在1周期间两组均未恢复至收缩期壁增厚。局部血流量存在差异;在冠状动脉闭塞期间,尼索地平使非缺血区和缺血区的心内膜和心外膜血流量显著增加。再灌注时每分钟心律失常搏动次数存在主要差异;在再灌注期间,溶媒治疗组的心律失常次数显著增加,而尼索地平治疗组实际上减少。两组中危险区域大小、梗死面积、与危险区域相关的梗死面积以及血液中出现的总肌酸激酶(CK)和MB-CK量均无显著差异。因此,在清醒狒狒中,冠状动脉闭塞后1小时给予尼索地平在减少再灌注诱导的心律失常方面发挥了显著作用,并在闭塞期间改善了缺血区的血流,但未挽救缺血组织。